Oesophageal motility defects associated with nocturnal gastro‐oesophageal reflux on proton pump inhibitors
Oesophageal motility defects associated with nocturnal gastro‐oesophageal reflux on proton pump inhibitors
复制标题
质子泵抑制剂与夜间胃食管反流相关的食管动力缺陷
DOI:
10.1046/j.1365-2036.1999.00641.x
复制
发表时间:
1999
影响因子:
7.6
通讯作者:
Donald O. Castell
中科院分区:
文献类型:
--
作者:
Y. M. Fouad;Philip O. Katz;Donald O. Castell
: Recent studies from our laboratory reveal that 70% of patients with gastro‐oesophageal reflux disease (GERD) on proton pump inhibitors twice daily (b.d.) have nocturnal gastric acid breakthrough (gastric pH < 4 > 1 h) which is often accompanied by oesophageal acid exposure. The pathogenesis of GER during gastric acid breakthrough is not clear.